Skip to main content
. 2022 Dec;14(12):4846–4864. doi: 10.21037/jtd-22-1524

Figure 7.

Figure 7

DFS for Group 2. Group 2 is the intermediate-grade predominant group, which includes papillary and acinar nodule subtypes. DFS, disease-free survival.